From artificial intelligence to nanotechnology
(ANSA) – TURIN, 07 JUL – Teoresi, an international engineering services company based in Turin, has become a partner of bioPmed, the Piedmontese innovation hub in the healthcare and life sciences sectors, made up of about 400 members, including companies, of research, foundations and associations, with the aim of continuing the experiments that for some years has been conducting on frontier technologies for the medicine of the future and creating new synergies with the territory. Among the frontier technologies that are already defining the medicine of the future, Teoresi identifies 5: Artificial Intelligence and machine learning applied to telemedicine, the use of in silico and digital twin models to test drugs, wearable devices for the safety of patients, nanotechnology applied to cancer research and augmented reality to slow the cognitive decline of the elderly. “The partnership with BioPMed demonstrates our interest in guiding the research and identification of solutions that are concretely applicable in the context of the markets and of the main trends in the field of medicine, in order to have an impact not only on the health of patients but also in the health system “, explains Beatrice Borgia, Teoresi’s chief corporate development officer. (HANDLE).
breaking latest news © Copyright ANSA